Letter to the editor: Is PAI-1 a thrombotic biomarker in NASH cirrhosis?

Hepatology. 2022 Jul;76(1):E16-E17. doi: 10.1002/hep.32392. Epub 2022 Feb 17.

Authors

Alberto Zanetto¹, Elena Campello², Luca Spiezia², Patrizia Burra¹, Paolo Simioni², Marco Senzolo¹

Affiliations

¹ Gastroenterology and Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Padova University Hospital, Padova, Italy.
² General Internal Medicine and thrombotic and Hemorrhagic Diseases Unit, Padova University Hospital, Padova, Italy.

PMID: 35112379
DOI: 10.1002/hep.32392

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Humans
Liver Cirrhosis / diagnosis
Non-alcoholic Fatty Liver Disease*
Plasminogen Activator Inhibitor 1
Thrombosis*

Substances

Biomarkers
Plasminogen Activator Inhibitor 1